Research News

Recent News

Comparing Selumetinib and Olaparib to Selumetinib Alone for Ovarian and Endometrial Cancers with RAS Pathway Mutations (EAY191-N4, A ComboMATCH Treatment Trial)

Read More

Fulvestrant and Binimetinib Targeted Treatment for NF1 Mutation in Hormone-Receptor Positive Metastatic Breast Cancer (EAY191-N2, A ComboMATCH Treatment Trial)

Read More

RTOG Foundation New Investigator Spotlight: Dr. Hyun Kim

Read More

NRG Oncology Combined Trial Long-Term Results Indicate that Pathologic Complete Response is Prognostic of Outcomes for Soft Tissue Sarcoma Patients

Read More

Three Week Hypo-fractionated Whole Breast Irradiation with Concurrent Boost is not Inferior to Conventional WBI with a Sequential Boost Following Lumpectomy for Patients with High-Risk, Early-Stage Breast Cancer

Read More

Multi-Modal Artificial Intelligence Models Offer a More Accurate Prognostication Method for Intermediate- to High-Risk Localized Prostate Cancer than Current NCCN Standard

Read More

Addition of Stereotactic Body Radiation Therapy to Sorafenib in Patients with Advanced Hepatocellular Carcinoma Improves Overall Survival

Read More

NRG Oncology Trial NRG-HN004 Shows Addition of Durvalumab to Radiation Does Not Improve Outcomes over Cetuximab for Head & Neck Squamous Cell Carcinoma Patients with a Contraindication to Cisplatin, Highlights Need for Further Research

Read More

CRI Managed Study to Examine COVID-19-related Financial Hardships that Impact TMIST Participation

Read More

Commission on Cancer Announces Annual Cancer Research Paper Competition

Read More

ACR Announces Request for Applications for Collaborative Research in Imaging Grant

Read More

Earn MIPS Improvement Activity Credits By Contributing COVID Images and Data to ACR Registries

Read More